Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Development and analytical performance of a new ARCHITECT automated dipeptidyl peptidase-4 immunoassay.

Hemken PM, Jeanblanc NM, Rae T, Brophy SE, Datwyler MJ, Xu Y, Manetz TS, Vainshtein I, Liang M, Xiao X, Chowdhury PS, Chang CY, Streicher K, Greenlees L, Ranade K, Davis GJ.

Pract Lab Med. 2017 Oct 20;9:58-68. doi: 10.1016/j.plabm.2017.10.003. eCollection 2017 Dec.

2.

Identification of unique proteomic signatures in allergic and non-allergic skin disease.

Wang J, Suárez-Fariñas M, Estrada Y, Parker ML, Greenlees L, Stephens G, Krueger J, Guttman-Yassky E, Howell MD.

Clin Exp Allergy. 2017 Nov;47(11):1456-1467. doi: 10.1111/cea.12979. Epub 2017 Aug 11.

PMID:
28703865
3.

Development of a new ARCHITECT automated periostin immunoassay.

Jeanblanc NM, Hemken PM, Datwyler MJ, Brophy SE, Manetz TS, Lee R, Liang M, Chowdhury PS, Varkey R, Grant EP, Streicher K, Greenlees L, Ranade K, Davis GJ.

Clin Chim Acta. 2017 Jan;464:228-235. doi: 10.1016/j.cca.2016.10.020. Epub 2016 Oct 14.

4.

Inhibition of myogenic microRNAs 1, 133, and 206 by inflammatory cytokines links inflammation and muscle degeneration in adult inflammatory myopathies.

Georgantas RW, Streicher K, Greenberg SA, Greenlees LM, Zhu W, Brohawn PZ, Higgs BW, Czapiga M, Morehouse CA, Amato A, Richman L, Jallal B, Yao Y, Ranade K.

Arthritis Rheumatol. 2014 Apr;66(4):1022-33. doi: 10.1002/art.38292.

5.

MicroRNA-206 induces G1 arrest in melanoma by inhibition of CDK4 and Cyclin D.

Georgantas RW 3rd, Streicher K, Luo X, Greenlees L, Zhu W, Liu Z, Brohawn P, Morehouse C, Higgs BW, Richman L, Jallal B, Yao Y, Ranade K.

Pigment Cell Melanoma Res. 2014 Mar;27(2):275-86. doi: 10.1111/pcmr.12200. Epub 2014 Jan 17.

PMID:
24289491
6.

Genomic signatures characterize leukocyte infiltration in myositis muscles.

Zhu W, Streicher K, Shen N, Higgs BW, Morehouse C, Greenlees L, Amato AA, Ranade K, Richman L, Fiorentino D, Jallal B, Greenberg SA, Yao Y.

BMC Med Genomics. 2012 Nov 21;5:53. doi: 10.1186/1755-8794-5-53.

7.
8.

Sustained effects of gene-activated matrices after CNS injury.

Berry M, Gonzalez AM, Clarke W, Greenlees L, Barrett L, Tsang W, Seymour L, Bonadio J, Logan A, Baird A.

Mol Cell Neurosci. 2001 Apr;17(4):706-16.

PMID:
11312606
9.

Prevalent expression of fibroblast growth factor (FGF) receptors and FGF2 in human tumor cell lines.

Chandler LA, Sosnowski BA, Greenlees L, Aukerman SL, Baird A, Pierce GF.

Int J Cancer. 1999 May 5;81(3):451-8.

Supplemental Content

Loading ...
Support Center